Microsoft word - microbiology_complete.doc


BL21(DE3)

F– ompT gal dcm lon hsdSB(rB- mB-) λ(DE3)
- an E. coli B strain with DE3, a λ prophage carrying the T7 RNA polymerase gene and lacIq
- Transformed plasmids containing T7 promoter driven expression are repressed until IPTG
induction of T7 RNA polymerase from a lac promoter.

BL21 (DE3) pLysS

F- ompT gal dcm lon hsdSB(rB- mB-) λ(DE3) pLysS(cmR)
- pLys plasmid chloramphenicol resistant; grow with chloramphenicol to retain plasmid
- Chloramphenicol resistant
- The pLysS plasmid encodes T7 phage lysozyme, an inhibitor for T7 polymerase which
reduces and almost eliminates expression from transformed T7 promoter containing plasmids
when not induced.

DB3.1

F- gyrA462 endA1 glnV44 ∆(sr1-recA) mcrB mrr hsdS20(rB-, mB-) ara14 galK2 lacY1 proA2
rpsL20 xyl5leu mtl1
- useful for propagating plasmids containing the ccdB gene (gyrA462 ).
- streptomycin resistant
DH5α

F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG Φ80lacZM15 ∆(lacZYA-argF)U169,
hsdR17(rK- mK+), λ–
- nalidixic acid resistant

DH10B (Invitrogen)

F- endA1 recA1 galU galK deoR nupG rpsLlacX74 Φ80lacZ∆M15 araD139
∆(ara,leu)7697 mcrA ∆(mrr-hsdRMS-mcrBC) λ-
- suitable for cloning methylated cytosine or adenine containing DNA
- Streptomycin resistant

JM109

endA1 glnV44 thi-1 relA1 gyrA96 recA1 mcrB+ ∆(lac-proAB) glnV44 e14- [F' traD36 proAB+
lacIq lacZM15] hsdR17(rK- mK+)
- Partly restriction-deficient; good strain for cloning repetitive DNA (RecA–).
- nalidixic acid resistant

SURE (Stratagene)

endA1 glnV44 thi-1 gyrA96 relA1 lac recB recJ sbcC umuC::Tn5 uvrC e14- ∆(mcrCB-
hsdSMR-mrr)171 F'[ proAB+ lacIq lacZM15 Tn10]
- increased stability for inverted repeats and Z-DNA
- nalidixic acid resistant
- kanamycin resistant
- tetracycline resistant

SURE2 (Stratagene)

endA1 glnV44 thi-1 gyrA96 relA1 lac recB recJ sbcC umuC::Tn5 uvrC e14- ∆(mcrCB-
hsdSMR-mrr)171 F'[ proAB+ lacIq lacZM15 Tn10 Amy CmR]
- increased stability for inverted repeats and Z-DNA
- nalidixic acid resistant
- kanamycin resistant
- tetracycline resistant
- chloramphenicol resistant for < 40 µg/ml, sensitive for > 100 µg/ml

XL1-Blue (Stratagene)

endA1 gyrA96 thi-1 recA1 relA1 lac glnV44 F'[ ::Tn10 proAB+ lacIq lacZM15] hsdR17(rK-
mK+)
- nalidixic acid resistant
- tetracycline resistant
SW102

F- endA1 recA1 galK deoR nupG rpsLlacX74 Φ80lacZ∆M15 araD139 ∆(ara,leu)7697
mcrA ∆(mrr-hsdRMS-mcrBC) [ λcI857 (cro-bioA) <>]
- Streptomycin resistant

Source: http://francois.schweisguth.free.fr/protocols/Bacterial_strains.pdf

vgt-ch.org

Dr. med. Alexander Walz Zelgmatt 5 CH-8132 Egg Switzerland Dr. Alexander Walz Zelgmatt 5 CH-8132 Egg Vasella/Novartis ./. Kessler/VGT In Ergänzung zur Stellungnahme vom 28.01.2010 Zum Vorwurf, es handele sich bei meiner Stellungnahme um ein reines Parteigutachten, welchem keinerlei Beweiswert zukäme, möchte ich Folgendes an Eides statt erklären: 1. Habe ich Herrn Dr. Kessler weder je

Microsoft word - rehsfil0.wwi

Bayer CropScience SCHEDA DI SICUREZZA secondo il Regolamento (CE) Num. 1907/2006 CURIT TRIO 1. IDENTIFICAZIONE DELLA SOSTANZA/PREPARATO E DELLA SOCIETÀ / IMPRESA Informazioni sul prodotto E-Mail: [email protected] (Indirizzo di posta elettronica al quale inviare esclusivamente richieste relative ai contenuti tecnici della scheda di sicurezza.) +39 02-3978 2282 (Numer

Copyright © 2018 Medical Abstracts